Jynneos

Pharma

Bavarian Nordic's largest shareholder objects to $3B buyout bid

While the vaccine maker's board unanimously backs the $3 billion price, its largest shareholder said it doesn't reflect the potential of the business.

Angus Liu Jul 28, 2025 10:31am

NIH study shows mpox shot elicits immune response in teens

Oct 17, 2024 11:17am

UNICEF taps Bavarian Nordic for 1M mpox vaccines

Sep 27, 2024 11:27am

Bavarian Nordic eyes partnerships to produce more mpox vaccines

Sep 12, 2024 12:15pm

Bavarian Nordic inks another supply deal for smallpox/mpox shot

Aug 22, 2024 2:13pm

Bavarian Nordic poised to deliver 10M mpox vaccines to Africa

Aug 19, 2024 11:03am